ILA 33.5
(7.03%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | 71.7 Million | 54.16 Million | 71.7 Million | 15.4 Million | 10.4 Million | -8.19 Million |
Net Income | -35.32 Million | -15.41 Million | -35.32 Million | -2.48 Million | 3.94 Million | -3.91 Million |
Depreciation & Amortization | 55.98 Million | 52.66 Million | 55.98 Million | 13.09 Million | 6.12 Million | 6.63 Million |
Deferred income taxes | - | -33 Thousand | 11.79 Million | 6064.46 | -8762.15 | - |
Stock-based compensation | 93 Thousand | 169 Thousand | 93 Thousand | 440 Thousand | 202.32 Thousand | 28.19 Thousand |
Change in working capital | 5.85 Million | -12.34 Million | 5.85 Million | -2.8 Million | -2.4 Million | -16.79 Million |
Other non-cash items | 44.81 Million | 29.12 Million | 33.02 Million | 7.45 Million | 2.53 Million | 5.85 Million |
Investing Cash Flow | -15.52 Million | 30.2 Million | -15.52 Million | 3.11 Million | 7.64 Million | -74.76 Million |
Investments in PPE | -387 Thousand | -491 Thousand | -387 Thousand | -6.9 Million | -10.75 Million | -42.74 Million |
Acquisitions | - | 235 Thousand | 509 Thousand | 228.71 Thousand | - | 74.8 Thousand |
Investment purchases | -86.17 Million | -9.19 Million | -86.17 Million | -10.84 Million | - | -11.48 Million |
Sales/Maturities of investments | 71.97 Million | 41.09 Million | 71.97 Million | 3.27 Million | 5.84 Million | 5.88 Million |
Other Investing Activities | -933 Thousand | -1.44 Million | -1.44 Million | 17.37 Million | 12.56 Million | -26.49 Million |
Financing Cash Flow | -88.35 Million | -71.71 Million | -88.35 Million | -12.43 Million | -10.35 Million | 84.3 Million |
Debt repayment | -41.94 Million | -47.11 Million | -41.94 Million | -21.89 Million | -7.37 Million | -5.06 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 8.29 Million | - | - | 2.85 Million | 232.59 Thousand | - |
Other Financing Activities | -46.41 Million | -24.59 Million | -46.41 Million | 6.59 Million | -3.21 Million | 89.36 Million |
Accounts receivables | -2.76 Million | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -6.53 Million | - | - | - | - | - |
Cash at beginning of period | 104.41 Million | 75.58 Million | 104.41 Million | 23.19 Million | 14.24 Million | 13.06 Million |
Cash at end of period | 75.58 Million | 90.2 Million | 75.58 Million | 30.15 Million | 21.32 Million | 15.43 Million |
Capital Expenditure | -387 Thousand | -491 Thousand | -387 Thousand | -6.9 Million | -10.75 Million | -42.74 Million |
Effect of forex changes on cash | 3.33 Million | 1.95 Million | 3.33 Million | 872.7 Thousand | -608.83 Thousand | 1.02 Million |
Net cash flow / Change in cash | -28.83 Million | 14.61 Million | -28.83 Million | 6.96 Million | 7.08 Million | 2.36 Million |
Free Cash Flow | 71.32 Million | 53.67 Million | 71.32 Million | 8.5 Million | -356.06 Thousand | -50.94 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -913 Thousand | 704 Thousand | -65.7 Million | -2.72 Million | -2.56 Million | -1.82 Million |
Depreciation & Amortization | 13.09 Million | 13.14 Million | 121.9 Million | 13.13 Million | 13.11 Million | 13.09 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 4000.00 | 11 Thousand | 50.6 Thousand | 14 Thousand | 30 Thousand | 31 Thousand |
Change in working capital | -4.18 Million | 10.56 Million | -1.27 Million | -842 Thousand | -329 Thousand | 18.85 Million |
Other non-cash items | 869 Thousand | 272 Thousand | -16.49 Million | 1.48 Million | 1.64 Million | 1.91 Million |
Investing Cash Flow | -7.82 Million | -20.88 Million | -30.55 Million | -9.25 Million | -10.23 Million | -28.37 Million |
Investments in PPE | -41 Thousand | -101 Thousand | 3.55 Million | -464 Thousand | -530 Thousand | -344 Thousand |
Acquisitions | - | - | - | -155 Thousand | - | - |
Investment purchases | -436 Thousand | - | - | - | -360 Thousand | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -8.52 Million | -21.59 Million | -34.11 Million | -8.63 Million | -9.34 Million | -28.02 Million |
Financing Cash Flow | -3.64 Million | -4.65 Million | -13.27 Million | -3.64 Million | -3.65 Million | 935 Thousand |
Debt repayment | - | - | -13.27 Million | -13.91 Million | -13.53 Million | -16.83 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | 5.61 Million |
Other Financing Activities | -3.64 Million | - | - | - | 9.88 Million | 12.15 Million |
Accounts receivables | -7.33 Million | - | -20.86 Million | -820.11 Thousand | -10.46 Million | 51.67 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 3.14 Million | - | 19.58 Million | 9.46 Million | 10.13 Million | -32.82 Million |
Cash at beginning of period | 43.37 Million | 44.71 Million | 170.22 Million | 47.5 Million | 50.35 Million | 46.73 Million |
Cash at end of period | 40.14 Million | 43.37 Million | 161.62 Million | 44.62 Million | 47.5 Million | 50.35 Million |
Capital Expenditure | -41 Thousand | -101 Thousand | 3.55 Million | -464 Thousand | -530 Thousand | -344 Thousand |
Effect of forex changes on cash | -623 Thousand | -495 Thousand | 5.68 Million | -1.04 Million | -858 Thousand | -1.01 Million |
Net cash flow / Change in cash | -3.22 Million | -1.33 Million | -8.6 Million | -2.87 Million | -2.85 Million | 3.61 Million |
Free Cash Flow | 8.82 Million | 24.59 Million | 42.02 Million | 10.6 Million | 11.36 Million | 31.72 Million |
0P49
SMSPHARMA
STLJF
SPFY
002564
TPX